Cargando…
Paving the Way Towards Universal Chimeric Antigen Receptor Therapy in Cancer Treatment: Current Landscape and Progress
Chimeric antigen receptor (CAR) therapy has been proved effective in a stream of clinical trials, especially in hematologic malignancies. However, current CAR therapy is highly personalized as cells used are derived from patients themselves, which can be costly, time-consuming, and sometimes fails t...
Autores principales: | Zhang, Yixi, Li, Pan, Fang, Hongyu, Wang, Guocan, Zeng, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758418/ https://www.ncbi.nlm.nih.gov/pubmed/33362790 http://dx.doi.org/10.3389/fimmu.2020.604915 |
Ejemplares similares
-
Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
por: Grywalska, Ewelina, et al.
Publicado: (2020) -
Engineering γδ T Cells: Recognizing and Activating on Their Own Way
por: Dong, Ruoyu, et al.
Publicado: (2022) -
Paving the way toward better peer review
Publicado: (2016) -
Excellence paves the way with Current Research in Toxicology
por: Knudsen, Thomas B., et al.
Publicado: (2020) -
The landscape of chimeric antigen receptor T cell therapy in breast cancer: Perspectives and outlook
por: Zhang, Hao, et al.
Publicado: (2022)